Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.

T.S. Waddell; I. Chau; C. Peckitt; D. Gonzalez; A. Wotherspoon; B. Patel; G.W. Middleton; J. Wadsley; D. Ferry; W. Mansoor; T.D.L. Crosby; F.Y. Coxon; D. Smith; J.S. Waters; T. Iveson; S. Falk; S. Slater; A.F.C. Okines; D. Cunningham

Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.

T.S. Waddell, I. Chau, C. Peckitt, D. Gonzalez, A. Wotherspoon, B. Patel, G.W. Middleton, J. Wadsley, D. Ferry, W. Mansoor, T.D.L. Crosby, F.Y. Coxon, D. Smith, J.S. Waters, T. Iveson, S. Falk, S. Slater, A.F.C. Okines, D. Cunningham

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Other contribution to conference › peer-review

Original language	English
Publication status	Published - 20 May 2014

Access to Document

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358613203230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9

Cite this

Waddell, T. S., Chau, I., Peckitt, C., Gonzalez, D., Wotherspoon, A., Patel, B., Middleton, G. W., Wadsley, J., Ferry, D., Mansoor, W., Crosby, T. D. L., Coxon, F. Y., Smith, D., Waters, J. S., Iveson, T., Falk, S., Slater, S., Okines, A. F. C., & Cunningham, D. (2014). Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358613203230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9

@conference{9c54d225adbd4299b4dbbe0a973618eb,

title = "Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.",

author = "T.S. Waddell and I. Chau and C. Peckitt and D. Gonzalez and A. Wotherspoon and B. Patel and G.W. Middleton and J. Wadsley and D. Ferry and W. Mansoor and T.D.L. Crosby and F.Y. Coxon and D. Smith and J.S. Waters and T. Iveson and S. Falk and S. Slater and A.F.C. Okines and D. Cunningham",

year = "2014",

month = may,

day = "20",

language = "English",

}

Waddell, TS, Chau, I, Peckitt, C, Gonzalez, D, Wotherspoon, A, Patel, B, Middleton, GW, Wadsley, J, Ferry, D, Mansoor, W, Crosby, TDL, Coxon, FY, Smith, D, Waters, JS, Iveson, T, Falk, S, Slater, S, Okines, AFC & Cunningham, D 2014, 'Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.'. <http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358613203230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9>

TY - CONF

T1 - Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.

AU - Waddell, T.S.

AU - Chau, I.

AU - Peckitt, C.

AU - Gonzalez, D.

AU - Wotherspoon, A.

AU - Patel, B.

AU - Middleton, G.W.

AU - Wadsley, J.

AU - Ferry, D.

AU - Mansoor, W.

AU - Crosby, T.D.L.

AU - Coxon, F.Y.

AU - Smith, D.

AU - Waters, J.S.

AU - Iveson, T.

AU - Falk, S.

AU - Slater, S.

AU - Okines, A.F.C.

AU - Cunningham, D.

PY - 2014/5/20

Y1 - 2014/5/20

M3 - Other contribution to conference

ER -